• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型的与MET相互作用的蛋白质RanBPM激活Ras/Erk信号通路。

Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM.

作者信息

Wang Dakun, Li Zaibo, Messing Edward M, Wu Guan

机构信息

Department of Urology, The James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, New York 14642, USA.

出版信息

J Biol Chem. 2002 Sep 27;277(39):36216-22. doi: 10.1074/jbc.M205111200. Epub 2002 Jul 29.

DOI:10.1074/jbc.M205111200
PMID:12147692
Abstract

MET is a receptor protein-tyrosine kinase (RPTK) for hepatocyte growth factor (HGF), which is a multifunctional cytokine controlling cell growth, morphogenesis, and motility. MET overexpression has been identified in a variety of human cancers. Oncogenic missense mutations of the tyrosine kinase domain of the MET gene have been identified in human papillary renal cell carcinomas. In this study, RanBPM, also known as RanBP9, is identified as a novel interacting protein of MET through yeast two-hybrid screen. RanBPM contains a conserved SPRY (repeats in splA and RyR) domain. We demonstrate that RanBPM can interact with MET in vitro and in vivo, and the interaction can be strengthened by HGF stimulation. RanBPM interacts with the tyrosine kinase domain of MET through its SPRY domain. We show that RanBPM can induce GTP-Ras association and Erk phosphorylation and elevate serum response element-luciferase (SRE-LUC) expression, indicating that RanBPM can activate the Ras-Erk-SRE pathway. We demonstrate that RanBPM, which itself is not a guanine exchange protein, stimulates Ras activation by recruiting Sos. On the cellular level, A704 cells, a human renal carcinoma cell line, transfected with RanBPM exhibit increased migration ability. Our data suggest that RanBPM, functioning as an adaptor protein for the MET tyrosine kinase domain, can augment the HGF-MET signaling pathway and that RanBPM overexpression may cause constitutive activation of the Ras signaling pathway.

摘要

MET是肝细胞生长因子(HGF)的一种受体蛋白酪氨酸激酶(RPTK),HGF是一种控制细胞生长、形态发生和运动的多功能细胞因子。MET的过表达已在多种人类癌症中被发现。在人类乳头状肾细胞癌中已鉴定出MET基因酪氨酸激酶结构域的致癌错义突变。在本研究中,RanBPM,也称为RanBP9,通过酵母双杂交筛选被鉴定为MET的一种新型相互作用蛋白。RanBPM包含一个保守的SPRY(splA和RyR中的重复序列)结构域。我们证明RanBPM在体外和体内均可与MET相互作用,并且这种相互作用可被HGF刺激增强。RanBPM通过其SPRY结构域与MET的酪氨酸激酶结构域相互作用。我们表明RanBPM可诱导GTP-Ras结合和Erk磷酸化,并提高血清反应元件荧光素酶(SRE-LUC)的表达,表明RanBPM可激活Ras-Erk-SRE途径。我们证明本身并非鸟嘌呤交换蛋白的RanBPM通过招募Sos刺激Ras激活。在细胞水平上,转染了RanBPM的人肾癌细胞系A704细胞表现出增强的迁移能力。我们的数据表明,作为MET酪氨酸激酶结构域的衔接蛋白,RanBPM可增强HGF-MET信号通路,并且RanBPM的过表达可能导致Ras信号通路的组成性激活。

相似文献

1
Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPM.一种新型的与MET相互作用的蛋白质RanBPM激活Ras/Erk信号通路。
J Biol Chem. 2002 Sep 27;277(39):36216-22. doi: 10.1074/jbc.M205111200. Epub 2002 Jul 29.
2
A novel MET-interacting protein shares high sequence similarity with RanBPM, but fails to stimulate MET-induced Ras/Erk signaling.一种新型的与MET相互作用的蛋白质与RanBPM具有高度的序列相似性,但无法刺激MET诱导的Ras/Erk信号传导。
Biochem Biophys Res Commun. 2004 Jan 9;313(2):320-6. doi: 10.1016/j.bbrc.2003.11.124.
3
The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathway.含SPRY结构域的细胞因子信号转导抑制因子盒蛋白1(SSB-1)与MET相互作用,并增强肝细胞生长因子诱导的Erk-Elk-1-血清反应元件通路。
J Biol Chem. 2005 Apr 22;280(16):16393-401. doi: 10.1074/jbc.M413897200. Epub 2005 Feb 15.
4
The Ran binding protein RanBPM interacts with TrkA receptor.Ran结合蛋白RanBPM与TrkA受体相互作用。
Neurosci Lett. 2006 Oct 16;407(1):26-31. doi: 10.1016/j.neulet.2006.06.059. Epub 2006 Sep 7.
5
RanBPM is an L1-interacting protein that regulates L1-mediated mitogen-activated protein kinase activation.RanBPM是一种与L1相互作用的蛋白质,可调节L1介导的丝裂原活化蛋白激酶激活。
J Neurochem. 2005 Aug;94(4):1102-10. doi: 10.1111/j.1471-4159.2005.03254.x. Epub 2005 Jul 5.
6
The Ran binding protein RanBPM interacts with Axl and Sky receptor tyrosine kinases.Ran结合蛋白RanBPM与Axl和Sky受体酪氨酸激酶相互作用。
Int J Biochem Cell Biol. 2005 Nov;37(11):2344-56. doi: 10.1016/j.biocel.2005.05.006.
7
Serine/threonine kinase Mirk/Dyrk1B is an inhibitor of epithelial cell migration and is negatively regulated by the Met adaptor Ran-binding protein M.丝氨酸/苏氨酸激酶Mirk/Dyrk1B是上皮细胞迁移的抑制剂,受甲硫氨酸衔接蛋白Ran结合蛋白M的负调控。
J Biol Chem. 2003 Dec 5;278(49):49573-81. doi: 10.1074/jbc.M307556200. Epub 2003 Sep 18.
8
A novel nuclear protein, Twa1, and Muskelin comprise a complex with RanBPM.一种新型核蛋白Twa1与肌动蛋白结合蛋白(Muskelin)共同构成了一种与RanBPM的复合物。
Gene. 2003 Jan 16;303:47-54. doi: 10.1016/s0378-1119(02)01153-8.
9
The cyclin-dependent kinase 11(p46) isoform interacts with RanBPM.细胞周期蛋白依赖性激酶11(p46)亚型与RanBPM相互作用。
Biochem Biophys Res Commun. 2003 Oct 10;310(1):14-8. doi: 10.1016/j.bbrc.2003.08.116.
10
Structural and functional characterization of the USP11 deubiquitinating enzyme, which interacts with the RanGTP-associated protein RanBPM.与RanGTP相关蛋白RanBPM相互作用的USP11去泛素化酶的结构和功能特征
Biochem J. 2002 Oct 1;367(Pt 1):87-95. doi: 10.1042/BJ20011851.

引用本文的文献

1
RANBP9 and RANBP10 cooperate in regulating non-small cell lung cancer proliferation.RANBP9和RANBP10在调节非小细胞肺癌增殖方面相互协作。
J Exp Clin Cancer Res. 2025 Aug 29;44(1):259. doi: 10.1186/s13046-025-03491-8.
2
Targeting DNA Damage Response-Mediated Resistance in Non-Small Cell Lung Cancer: From Mechanistic Insights to Drug Development.靶向非小细胞肺癌中DNA损伤反应介导的耐药性:从机制洞察到药物开发
Curr Oncol. 2025 Jun 23;32(7):367. doi: 10.3390/curroncol32070367.
3
Exploring NNMT: from metabolic pathways to therapeutic targets.
探索NNMT:从代谢途径到治疗靶点。
Arch Pharm Res. 2024 Dec;47(12):893-913. doi: 10.1007/s12272-024-01519-9. Epub 2024 Nov 28.
4
Synthesis and biological evaluation of novel 2-morpholino-4-anilinoquinoline derivatives as antitumor agents against HepG2 cell line.新型2-吗啉基-4-苯胺基喹啉衍生物作为抗肝癌HepG2细胞系抗肿瘤剂的合成及生物学评价
RSC Adv. 2024 Jan 19;14(5):3304-3313. doi: 10.1039/d3ra07495a. eCollection 2024 Jan 17.
5
Novel Targets, Novel Treatments: The Changing Landscape of Non-Small Cell Lung Cancer.新型靶点与新型疗法:非小细胞肺癌不断变化的格局
Cancers (Basel). 2023 May 21;15(10):2855. doi: 10.3390/cancers15102855.
6
B cell linker protein (BLNK) is a regulator of Met receptor signaling and trafficking in non-small cell lung cancer.B细胞连接蛋白(BLNK)是一种调节非小细胞肺癌中Met受体信号传导和转运的蛋白。
iScience. 2022 Oct 20;25(11):105419. doi: 10.1016/j.isci.2022.105419. eCollection 2022 Nov 18.
7
Complex roles of nicotinamide N-methyltransferase in cancer progression.烟酰胺 N-甲基转移酶在癌症进展中的复杂作用。
Cell Death Dis. 2022 Mar 25;13(3):267. doi: 10.1038/s41419-022-04713-z.
8
Minibrain-related kinase/dual-specificity tyrosine-regulated kinase 1B implication in stem/cancer stem cells biology.微小脑相关激酶/双特异性酪氨酸调节激酶1B在干细胞/癌症干细胞生物学中的作用
World J Stem Cells. 2020 Dec 26;12(12):1553-1575. doi: 10.4252/wjsc.v12.i12.1553.
9
Ran GTPase: A Key Player in Tumor Progression and Metastasis.Ran GTP酶:肿瘤进展和转移中的关键因子
Front Cell Dev Biol. 2020 May 26;8:345. doi: 10.3389/fcell.2020.00345. eCollection 2020.
10
The CTLH Complex in Cancer Cell Plasticity.癌细胞可塑性中的CTLH复合体
J Oncol. 2019 Nov 30;2019:4216750. doi: 10.1155/2019/4216750. eCollection 2019.